Capricor Therapeutics (CAPR) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to -$24.6 million.
- Capricor Therapeutics' Profit After Tax fell 9567.71% to -$24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$70.2 million, marking a year-over-year decrease of 10565.6%. This contributed to the annual value of -$40.5 million for FY2024, which is 8156.86% down from last year.
- As of Q3 2025, Capricor Therapeutics' Profit After Tax stood at -$24.6 million, which was down 9567.71% from -$25.9 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Profit After Tax registered a high of -$762089.0 during Q4 2023, and its lowest value of -$25.9 million during Q2 2025.
- For the 5-year period, Capricor Therapeutics' Profit After Tax averaged around -$9.2 million, with its median value being -$7.2 million (2023).
- Its Profit After Tax has fluctuated over the past 5 years, first surged by 9012.95% in 2023, then plummeted by 83382.83% in 2024.
- Over the past 5 years, Capricor Therapeutics' Profit After Tax (Quarter) stood at -$6.2 million in 2021, then fell by 24.72% to -$7.7 million in 2022, then soared by 90.13% to -$762089.0 in 2023, then crashed by 833.83% to -$7.1 million in 2024, then plummeted by 245.26% to -$24.6 million in 2025.
- Its Profit After Tax was -$24.6 million in Q3 2025, compared to -$25.9 million in Q2 2025 and -$7.1 million in Q4 2024.